Compare StocksABBV vs IT

AbbVie Inc. (ABBV) vs Gartner, Inc. (IT): Which Is the Better Buy in 2026?

As of 2026-06-19, ABBV is overvalued at $216, with a DCF intrinsic value of $160 and a margin of safety of -35%. IT is undervalued at $127, with an intrinsic value of $304 and a margin of safety of 58%. Of the two, IT has the wider margin of safety.

ABBV
AbbVie Inc.
$216.49
VS
IT
Gartner, Inc.
$127.49

Rewards

ABBV
  • AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 72.0% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
IT
  • Gartner, Inc. has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • Gross margin of 69.0% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Gartner, Inc. scores 97/100 on the Economic Moat Score (Wide Moat), with roic consistency as the strongest competitive dimension.

Risks

ABBV
  • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • FCF yield of 5.4% suggests reasonable valuation assuming continued moderate growth.
  • Trailing P/E of 105.6x is 69% above the historical average of 62.3x — the stock trades at a premium to its own history.
IT
  • High leverage (26.63x net debt/equity) combined with thin interest coverage (-1.0x) poses financial risk.

Key Valuation Metrics

Learn more →
ABBV
IT
Valuation
$20.81B
Free Cash Flow
$1.06B
5.44%
FCF Yield
12.47%
105.60
Trailing P/E
12.61
13.32
Forward P/E
8.33
Quality & Moat
21.89%
ROIC
30.67%
N/A
ROE
94.88%
72.03%
Gross Margin
68.99%
0.61
PEG Ratio
0.57
Balance Sheet Safety
N/A
Net Debt / Equity
26.63
N/A
Interest Coverage
N/A
2.12
Net Debt / EBITDA
1.26
3.11%
Dividend Yield
0.00%
ABBV: 2Ties: 2IT: 6
ABBVIT

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

IT

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
IT
$-3.05
created per $1 retained over 3 years
Market Cap Declined
Σ Retained
$2.87B
Δ Market Cap
$-8.74B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
35.3% Overvalued
Price is 35.3% above estimated fair value
Current Price: $216.49
Fair Value: $160.05
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
IT
58.1% Margin of Safety
Price is 58.1% below estimated fair value
Current Price: $127.49
Fair Value: $304.28
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

What growth rate is the market pricing in at $216?

+17.1%
Market-Implied Owner Earnings Growth
Standard FCF implies +8.7%

The market implies +17.1% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +8.7%, reflecting heavy growth investment.

IT

What growth rate is the market pricing in at $127?

+1.3%
Market-Implied Owner Earnings Growth
Standard FCF implies -2.4%

The market implies +1.3% Owner Earnings growth, roughly in line with history — reasonably priced.

Standard FCF implies -2.4%, reflecting ongoing growth investment.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
IT
97/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. ROIC Consistency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
IT
-2.91
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 76.9%Retail & Other 23.0%
No. of Institutional Holders5,106
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
IT
Insiders 3.5%Institutions 118.8%
No. of Institutional Holders1,072
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
IT
0
Buys (3M)
3
Buys (12M)
Total value (12M): $10.05M
RINELLO JOHN J
Officer
$7,706
@ $154.12 · 2026-02-05
PAGLIUCA STEPHEN G
Director
$9.94M
@ $229.57 · 2025-12-10
GUTIERREZ JOSE M.
Director
$99,997
@ $239.80 · 2025-08-18
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
0
Sells (3M)
5
Sells (12M)
Total value (12M): $21.79M
PURDUE DAVID R.
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
GONZALEZ RICHARD A
Officer and Director
$12.40M
@ $186.52 · 2024-08-05
GONZALEZ RICHARD A
Officer and Director
$49.50M
@ $175.00 · 2024-07-17
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
IT
0
Sells (3M)
3
Sells (12M)
Total value (12M): $161,708
HERKES CLAIRE L
Officer
$84,983
@ $231.56 · 2025-12-03
RINELLO JOHN J
Officer
$50,505
@ $229.57 · 2025-12-03
RINELLO JOHN J
Officer
$26,220
@ $249.71 · 2025-08-22
FUCHS ANNE SUTHERLAND
Director
$270,705
@ $413.29 · 2025-06-12
DYKSTRA KAREN E
Director
$792,439
@ $421.51 · 2025-06-09
HENSEL SCOTT
Officer
$2.42M
@ $448.78 · 2025-05-21
JAIN AKHIL
Officer
$281,250
@ $450.00 · 2025-05-19
HERKES CLAIRE L
Officer
$84,068
@ $447.17 · 2025-05-16
JAIN AKHIL
Officer
$11,250
@ $450.00 · 2025-05-15
WARTINBEE WILLIAM JAMES III
Officer
$241,610
@ $449.09 · 2025-05-13
SAFIAN CRAIG W
Chief Financial Officer
$1.54M
@ $450.17 · 2025-05-13
KRANICH ROBIN B.
Officer
$322,574
@ $436.50 · 2025-05-07
RINELLO JOHN J
Officer
$47,562
@ $436.35 · 2025-05-07
RINELLO JOHN J
Officer
$44,387
@ $493.19 · 2025-02-27
GENOVESE YVONNE
Officer
$881,258
@ $506.47 · 2025-02-26
SERRA EILEEN
Director
$587,724
@ $489.77 · 2025-02-24
RINELLO JOHN J
Officer
$47,746
@ $530.51 · 2025-02-10
GENOVESE YVONNE
Officer
$89,931
@ $519.83 · 2024-12-11
WARTINBEE WILLIAM JAMES III
Officer
$98,949
@ $523.54 · 2024-12-06
HERKES CLAIRE L
Officer
$214,229
@ $521.24 · 2024-11-27
SMITH JAMES C
Director
$2.62M
@ $524.02 · 2024-11-26
BISSON PETER E
Director
$921,367
@ $528.61 · 2024-11-15
SMITH JAMES C
Director
$6.98M
@ $552.79 · 2024-11-13
JAIN AKHIL
Officer
$165,652
@ $554.02 · 2024-11-13
HENSEL SCOTT
Officer
$888,000
@ $555.00 · 2024-11-13
SMITH JAMES C
Director
$12.47M
@ $548.48 · 2024-11-12
DAWKINS ALWYN
Officer
$550,340
@ $550.34 · 2024-11-12
SRIBAR VALENTIN T
Officer
$475,580
@ $553.00 · 2024-11-11
BECK JOSEPH P
Officer
$1.35M
@ $553.34 · 2024-11-11
ALLARD KENNETH
Officer
$880,952
@ $548.88 · 2024-11-11
SAFIAN CRAIG W
Chief Financial Officer
$1.94M
@ $550.81 · 2024-11-11
HALL EUGENE A.
Chief Executive Officer
$9.99M
@ $546.24 · 2024-11-08
DAWKINS ALWYN
Officer
$1.09M
@ $546.80 · 2024-11-08
JAIN AKHIL
Officer
$121,878
@ $549.00 · 2024-11-08
SMITH JAMES C
Director
$7.76M
@ $537.20 · 2024-11-07
DYKSTRA KAREN E
Director
$793,530
@ $529.02 · 2024-11-06
HERKES CLAIRE L
Officer
$241,873
@ $506.01 · 2024-09-13
HALL EUGENE A.
Chief Executive Officer
$17.21M
@ $505.40 · 2024-09-12
SMITH JAMES C
Director
$3.95M
@ $501.72 · 2024-09-12
SMITH JAMES C
Director
$1.06M
@ $500.15 · 2024-09-10
JAIN AKHIL
Officer
$246,000
@ $492.00 · 2024-09-09
WARTINBEE WILLIAM JAMES III
Officer
$103,276
@ $491.79 · 2024-09-09
DAWKINS ALWYN
Officer
$489,550
@ $489.55 · 2024-08-29
KRANICH ROBIN B.
Officer
$1.76M
@ $490.00 · 2024-08-29
HENSEL SCOTT
Officer
$2.73M
@ $490.00 · 2024-08-29
HERKES CLAIRE L
Officer
$323,757
@ $483.22 · 2024-08-27
GENOVESE YVONNE
Officer
$214,244
@ $483.62 · 2024-08-26
JAIN AKHIL
Officer
$194,000
@ $485.00 · 2024-08-15
SAFIAN CRAIG W
Chief Financial Officer
$3.05M
@ $483.57 · 2024-08-15
SMITH JAMES C
Director
$4.80M
@ $480.08 · 2024-08-13
SMITH JAMES C
Director
$2.39M
@ $478.26 · 2024-08-07
DYKSTRA KAREN E
Director
$783,521
@ $465.55 · 2024-08-05
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😐Neutral(56/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
IT
FearGreed
🥶Extreme Fear(17/100)

"Mr. Market is panicking — potential buying opportunity if fundamentals are strong"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (56)
IT
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Extreme Fear (17)
View ABBV Full AnalysisView IT Full Analysis

Frequently Asked Questions: ABBV vs IT

Is AbbVie Inc. or Gartner, Inc. more undervalued in 2026?

Based on our discounted cash flow model, IT trades at a 58.1% margin of safety (intrinsic value $304 vs. price $127), compared to ABBV's -35.3% margin of safety (intrinsic $160 vs. $216).

Which stock has a wider economic moat, AbbVie Inc. or Gartner, Inc.?

IT scores 97/100 (Wide moat), while ABBV scores 82/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is AbbVie Inc. in financial distress?

ABBV's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. IT scores 3.8 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which company has better free cash flow, AbbVie Inc. or Gartner, Inc.?

Gartner, Inc. (IT) generates a 12.5% free cash flow yield, compared to AbbVie Inc.'s 5.4%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, AbbVie Inc. or Gartner, Inc.?

IT earns 30.7% ROIC versus ABBV's 21.9%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.